Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Does vaccine promise put U.S. consumers in a shopping mood? Retailers may have clues

Published 11/16/2020, 06:14 PM
Updated 11/16/2020, 06:15 PM
© Reuters. FILE PHOTO: A shopper is seen wearing a mask while shopping at a Walmart store in Bradford, Pennsylvania

By Caroline Valetkevitch

NEW YORK (Reuters) - As positive coronavirus vaccine news makes strategists more optimistic about the future for retailers, investors will look to earnings results and forecasts from these companies in the coming days for clues about consumer spending.

The thinking is that effective vaccines will "translate into positive performances for discretionary," said Sam Stovall, chief investment strategist for CFRA, which recently raised its recommendation on the S&P 500 consumer discretionary sector (SPLRCD) to overweight from market weight.

The pandemic and restrictions on businesses have added to revenue struggles for some traditional retailers like department stores while boosting sales for Amazon (O:AMZN) and other sellers that have capitalized on the work-from-home phenomenon.

Results from Home Depot Inc. (N:HD), Walmart Inc. (N:WMT) and Kohl's Corp. (N:KSS) are due on Tuesday, while reports from Macy's Inc. (N:M), L Brands (N:LB), Target Corp. (N:TGT) and TJX Cos (N:TJX) are expected later this week.

The U.S. retail sales report for October also is due on Tuesday.

Investors will be especially eager to hear guidance and commentary from retail executives on consumer spending.

"We've gotten used to now buying online increasingly and delivery has become smoother," said Quincy Krosby, chief market strategist at Prudential Financial (NYSE:PRU) in Newark, New Jersey. "The question is, does it continue?"

Shares in a number of retailers rallied on Monday as a result of optimism that a COVID-19 vaccine will help the economic recovery in the months ahead.

Moderna Inc (O:MRNA) said its experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial. Pfizer Inc (N:PFE) said last week its experimental COVID-19 vaccine was more than 90% effective based on initial trial results.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Among the biggest percentage gainers in the S&P 500 consumer discretionary index on Monday were Gap Inc. (N:GPS), up 9.5%; Under Armour (N:UAA), up 5.8%; and Ulta Beauty (O:ULTA), up 4.9%.

Investors also are watching whether upcoming holiday sales data can support hopes for retailer shares despite a surge in COVID cases and increased restrictions across the United States and in Europe.

"As long as the jobs market holds up and we see (unemployment benefit claims) continuing to go down, that helps consumers' optimism," said Krosby.

Some retailers' shares remain down sharply this year so far, including Macy's, which is off more than 50% since Dec. 31 despite a 9% gain on Monday as the pandemic added to their recent struggles.

On the earnings front, there continues to be a big divide within the consumer discretionary sector.

Analysts expect the sector to post an earnings decline of 5.1% for the third quarter from a year ago, compared with a 7.4% decline for the entire S&P 500 (SPX), according to IBES data from Refinitiv.

But earnings for internet and direct marketing retail companies are show about a 43% rise in the quarter, while apparel retail earnings are forecast to fall 40.1%.

Nordstrom Inc (N:JWN), Gap Inc (N:GPS) and American Eagle Outfitters Inc (N:AEO) report earnings next week.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.